Generare
French tech company | Builders Republic
About
Biotech platform that decodes microbial genomes to discover previously inaccessible natural drug compounds — using high-throughput cloning, sequencing, and lab synthesis to express candidate gene clusters and characterize the resulting molecules for structure, biological activity, and drug potential.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2022
- City
- PARIS
- Region
- IDF
- Tracked rounds
- 2
- Amount raised
- 20 M€ raised since 2020
Funding rounds
- Series A — 2026
- Seed — 2024
Investors
- Alven
- Better Angle
- Daphni
- Galion.exe
- Saras Capital
- Synbioven
- Teampact Ventures
- Vives Partners